DOI QR코드

DOI QR Code

고려인삼의 주요 효능과 그 임상적 응용

Clinical Applications and Efficacy of Korean Ginseng

  • Nam, Ki-Yeul (Korea Ginseng and Tobacco Research Institute, Science Town)
  • 발행 : 2002.09.01

초록

본 총설은 1980년대부터 최근까지 국내외 학술잡지나 심포지움 등에 발표된 인삼의 주요 임상효능 연구결과를 요약 고찰하고, 그 임상 적응증과 안전성 등에 대한 검토를 통해 금후 인삼의 임상적 활용성 제고와 인삼의 진정한 약용가치 평가를 위한 임상연구의 발전에 도움을 주고자 하였다. 당뇨병을 비롯한 동맥경화성 질환, 고혈압, 악성질환, 성기능 장애 등의 만성질환에 대한 그 동안의 연구결과는 인삼의 치료효과보다는 예방 및 회복제로서의 효용성을 보여 주었다. 특히 이들 질환의 각종 자각적 장해증상과 장기 약물치료의 부작용으로 인한 QOL의 악화에 에 대한 개선효과가 관찰되었다. 그러나 인삼의 효과는 일반적으로 mild 하여 일차적 치료보다는 관행적 약물요법과 병용할 때 보조요법제로서 또는 부작용을 보다 적게 하는 효과가 기대된다. 또한 주요 강장효능과 관련하여 작업수행능력에 미치는 임상연구 결과는 인삼복용이 각종 스트레스 상태하의 신체적 조건에 대한 적응능력을 개선시켜 육체적 정신적 기능저하를 회복시키는 효과를 보였다. 이러한 임상시험에서 얻어진 결과가 그대로 인삼의 적응증(indication)이라고 단정할 수는 없으며, 그 효능의 과학적 증거들에 대해서는 아직도 논란이 많고, 임상실험의 유효성 평가와 관련된 방법론적 문제점도 많이 지적되고 있다. 보다 확실한 적응증 제시를 위해서는 표준화된 인삼시료를 이용하여 보다 체계적인 시험설계에 의한 객관적 효능평가가 필요하다. 한편 인삼(제품)복용에 의한 부작용(adverse effects)의 발생 가능성에 대한 사례보고들도 대부분 인삼의 과량복용이나 품질관리 미흡에서 기인되는 것으로 여겨지고 있다. 최근 해외 시장에서 유통되는 인삼제품 품질검사에서 사포닌 성분의 불검출 또는 함량 미달과 유해성분의 오염가능성 등 부정적 견해들이 다수 보고되었다. 그러나 표준화된 인삼제품의 추천 복용량을 사용한 대부분의 임상실험에서는 거의 유의할만한 부작용은 인정되지 않았다. 금후 연구와 관련하여, 품질표준의 지표성분으로 간주되는 진세노사이드의 절대함량과 그 성분조성 차이에 따른 임상효과의 차별성이 있는지에 대한 검토와, 특히 최근 실험적으로 밝혀지고 있는 사포닌 성분의 장내 세균에 의한 생물전환체의 인체 실험을 통한 효과 검정이 필요하다. 나아가서는 적정 복용량의 설정과 이와 관련되는 생체내 동태 및 생체이용율(bioavilability)에 관한 정보가 거의 없으므로 이것도 금후 검토해야 할 과제로 사료된다. 인삼은 전통약물로서 오랜 역사성과 그동안의 연구결과에 의한 과학성을 가지고 있으므로 건강유지와 병의 예방 및 회복촉진을 위한 보조요법제 또는 기능성 식품으로써의 유용성이 있는 것으로 판단된다. 앞으로 인삼의 활용성 증대를 위해서는 보다 과학적인 임상평가에 의한 안전성 및 유효성 입증과 제품의 엄격한 품질관리의 필요성이 더욱 강조되어야 할 것이다.

Korean ginseng (Panax ginseng C.A. Meyer) received a great deal of attention from the Orient and West as a tonic agent, health food and/or alternative herbal therapeutic agent. However, controversy with respect to scientific evidence on pharmacological effects especially, evaluation of clinical efficacy and the methodological approach still remains to be solved. Author reviewed those articles published since 1980 when pharmacodynamic studies on ginseng have intensively started. Special concern was paid on metabolic disorders including diabetes mellitus, circulatory disorders, malignant tumor, sexual dysfunction, and physical and mental performance to give clear information to those who are interested in pharmacological study of ginseng and to promote its clinical use. With respect to chronic diseases such as diabetes mellitus, atherosclerosis, high blood pressure, malignant disorders, and sexual disorders, it seems that ginseng plays preventive and restorative role rather than therapeutics. Particularly, ginseng plays a significant role in ameliorating subjective symptoms and preventing quality of life from deteriorating by long term exposure of chemical therapeutic agents. Also it seems that the potency of ginseng is mild, therefore it could be more effective when used concomitantly with conventional therapy. Clinical studies on the tonic effect of ginseng on work performance demonstrated that physical and mental dysfunction induced by various stresses are improved by increasing adaptability of physical condition. However, the results obtained from clinical studies cannot be mentioned in the indication, which are variable upon the scientist who performed those studies. In this respect, standardized ginseng product and providing planning of the systematic clinical research in double-blind randomized controlled trials are needed to assess the real efficacy for proposing ginseng indication. Pharmacological mode of action of ginseng has not yet been fully elucidated. Pharmacodynamic and pharmacokinetic researches reveal that the role of ginseng not seem to be confined to a given single organ. It has been known that ginseng plays a beneficial role in such general organs as central nervous, endocrine, metabolic, immune systems, which means ginseng improves general physical and mental conditons. Such multivalent effect of ginseng can be attributed to the main active component of ginseng,ginsenosides or non-saponin compounds which are also recently suggested to be another active ingredients. As is generally the similar case with other herbal medicines, effects of ginseng cannot be attributed as a given single compound or group of components. Diversified ingredients play synergistic or antagonistic role each other and act in harmonized manner. A few cases of adverse effect in clinical uses are reported, however, it is not observed when standardized ginseng products are used and recommended dose was administered. Unfavorable interaction with other drugs has also been suggested, which the information on the products and administered dosage are not available. However, efficacy, safety, interaction or contraindication with other medicines has to be more intensively investigated in order to promote clinical application of ginseng. For example, daily recommended doses per day are not agreement as 1-2g in the West and 3-6 g in the Orient. Duration of administration also seems variable according to the purpose. Two to three months are generally recommended to feel the benefit but time- and dose-dependent effects of ginseng still need to be solved from now on. Furthermore, the effect of ginsenosides transformed by the intestinal microflora, and differential effect associated with ginsenosides content and its composition also should be clinically evaluated in the future. In conclusion, the more wide-spread use of ginseng as a herbal medicine or nutraceutical supplement warrants the more rigorous investigations to assess its effacy and safety. In addition, a careful quality control of ginseng preparations should be done to ensure an acceptable standardization of commercial products.

키워드

참고문헌

  1. 남기열 : 최신고려인삼(성분과 효능편), 천일인쇄소, p. 56 (1996)
  2. Smith, M., Boon, H. S. : Patient Education and Counseling, 38, 109 (1999) https://doi.org/10.1016/S0738-3991(99)00058-0
  3. Kimura, M. and Suzuki,J : Advancesin Chinese Medicinal Materials Research edited by H.W. Chang, H W. Heung, W. W. Tso and A Koo. World Scientific Publ. Co., Singapore, 181 (1985)
  4. Sotaniemi, E. A., Haapakoski, E., Rautio, A. R. : Diabetes Care 18(10), 1373 (1995) https://doi.org/10.2337/diacare.18.10.1373
  5. Vuksan, V., Sung, M. K., Sievenpier,J. L., Buono, M. D. : Experimental Biology2002$\circledR $ New Orleans, Louisina April 20-24, Abstracts Part I, A647 (2002)
  6. Yano S. : Biomedicine & Therapeutics (Japan), 28(1), 63(1995)
  7. Yoshita, Y., et al. : Kisho & Linshiou, 16(10), 302 (1982)
  8. Yamamoto, M., et al. : Kisho & Linshiou, 17(6), 169 (1983)
  9. Okuda, H., Yoshida, R. : Proc. of the 2nd Int'l Ginseng Symp., Seoul, Korea, 53 (1980)
  10. Choi, D. S., Kim, S. J., Lee, K J., et al. : Proc fih Int, I Symp., Seoul, Korea, 102 (1993)
  11. Choi, K M., Lee, E. J., Kim, Y. H., et al. : Korean J. Ginseng Sci. 21(3), 153 (1997)
  12. Tetsutani, T., et al. : The Ginseng Review 10, 14 (1990)
  13. Tetsutani, T., et al. : The Ginseng Review 22, 119 (1996)
  14. Tetsutani, T., Yammmamura, M., Yamaguchi, T., Suzuki, S., Makino, H. and Onoyama, O. : The Ginseng Review 27, 86 (1999)
  15. Tetsutani, T, Yammmamura, M., Yamaguchi, T, Suzuki, S. and Onoyama O: The Ginseng Review 25, 28 (1998)
  16. Tetsutani, T, Yammmamura, M., Yamaguchi, T, Suzuki, S., Onoyama, O. and Kono M : The Ginseng Review 28, Japan, 44 (2000)
  17. Yamamoto, M., Uemura, T, Nakama, S., Uerniya, M. and Kumagai, A. : American J of Chinese Medicine 9(1-4), 96 (1983)
  18. Jin, E. Y., Shi, Z. X., Ke, Y. N., Huang, L. H., Yan, X. P., Wei, Y. L., Jin, M., Liu, P., Yang, L. X., Lee, K S., Nam, K. Y., Kumagai, A. : The Ginseng Review 24, 104 (1998)
  19. Yamamoto, M. and Kumagai, A. : Proc. 4th Int'l Ginseng Symp., Seoul, Korea, 13 (1984)
  20. Joo, C. N., Kang, I. C. and Lee, H. B : Korean J. Ginseng Sci. 12(2), 104 (1988)
  21. Joo, C. N., Lee, H. R, Lee, Y. Wand Kang, I. C. : Proc. 5th Int'l Ginseng Symp., Seoul, Korea, 47 (1988)
  22. Beltz, S. D. and Doering, P. L. : Clinical Pharmacy 12, 900(1993)
  23. Yamamoto, M., et al. : Japanese J Arteriosclerosis 9(4), 671 (1981)
  24. Yoon, S. H. and Joo, C. N. : Korean J. Ginseng Sci. 17(1), 1 (1993)
  25. Koo, J. H,, Noh, Y. H. and Lim, G. : Proc. of Korean-Japan Ginseng Symp. : Seoul, Korea, 91 (1997)
  26. Kwon, B. M., Kim, M. K, Nam, I. B., Kim, D. S., Park, J.D., Kim, Y. K, Lee, H. K, Kim, S. I. : Bioorganic & Medicinal Chemistry Letters 9, 1375 (1999) https://doi.org/10.1016/S0960-894X(99)00208-5
  27. Kwon, B. M., Ro, S. H., Kim, M. K., Nam, J. Y. and Bok, S. H. : Planta Med. 63, 552 (1997) https://doi.org/10.1055/s-2006-957763
  28. Nakanishi, K, et al. : Linshio & Kenkyhu 57(9), 323(1980)
  29. Yamamoto, M., et al. : Kisho & Linshiou 17(6), 178 (1983)
  30. Kaneko, H., et al. : Linshio&Kenkyhu, 60(12), 170 (1983)
  31. Tamura, Y., Hirai, A., Terano, T., Tahara, K, Saitoh, J., Kondo, S., Samukawa, K and Yoshida, S. : Proc. 6th Int'l Ginseng Symp., Seoul, Korea, 28 (1993)
  32. 田村泰, 平井愛山, 山本 恭平, 吉田 尙: 和漢醫學雜誌, 5, 260 (1988)
  33. Yamamoto, M. : The Ginseng Review, 24, 129-132 (1998)
  34. Punnonen, R. and Lukola, A. : Asia-Oceania. Gynaecol. 10(3), 399 (1984)
  35. Oh, B. H., Han, K H., Kim, Y. J. and Nam, K. Y. : Proc. of '99 Korea-Japan Ginseng Symposium, Seoul, Korea, 70 (1999)
  36. Sigel, R. K :J. of American Medical Association 241(15), 1614 (1979) https://doi.org/10.1001/jama.241.15.1614
  37. Sigel, R. K. : Proc. 3rd Int'l Ginseng symp, Seoul, Korea, 229 (1980)
  38. Owen, R. T. : Drugs of Today 27(8), 343 (1981).
  39. Yamamoto, M., et al. : The Ginseng Review 9, 15 (1990)
  40. Kaneko, H., Nakanishi, K, Kuwashima, K, et at. : Linsho & Kenkyu 58(12), 145 (1983)
  41. Jin, E. Y., Jin, M., Wei, Y. L., Huang, L. H., Yan, X. P., Shi, Z. X., Huang, L., Shen, D. C., Fu, R. J., Zhao, T. Y., Nam, K. Y. and Kumagai, A. : Advances in Ginseng Research, Proc. of the 7th Intl' Symp. on Ginseng, 22 (1998)
  42. Han, K. H., Choe, S. C., Kim, K. D., Sohn, D. W, Nam, K. Y., Oh, B. H., Lee, M. M., Park, Y. B., Choi, Y. S., Seo, J. D. and Lee, Y. W. : American J. of Chinese Medicine, 26(2), 199 (1998) https://doi.org/10.1142/S0192415X98000257
  43. Sohn, E. S., Huh, B. Y., Park, S. C., Park, C. W.and Kim, H. J. : Proc. 2nd Int'l Ginseng Symp. : 1 (1980)
  44. Imamura, Y. and Kuwashima, K : Proc. of the 5th Intl' Ginseng Symp. Seoul, 87 (1988)
  45. Kim, N. D. : Proc. of '99 Korea-Japan Ginseng Symp., 1 (1999)
  46. Jeon, R. H., Kim, C. S., Kim, H. S., Park, J. B., Nam, K. Y. and Chang, S. J. : Acta Pharmacol Sin 21(2), 1095 (2000)
  47. Oh, B. H., Zo, J. H., Han, K. H., Kim, C. H., Nam, K. Y. and Seo, J. D. : The Ginseng Review 27, 67 (1999)
  48. 高橋榮司 : The Ginseng Review, 6, 25 (1988)
  49. Kaneko : The Ginseng Review, 2, 183 (1984)
  50. Kim, N. D., Kim, B. K. and Lee, H. S. : Yakhak Hoeji 26(4), 239 (1982)
  51. Zhang, J. M., Matsuura, Y., Sueda, T., Orihashi, K, Fukunaga, S. and Watanabe, M. : Hiroshima J. Med. Sci. 48(2), 65 (1999)
  52. Yang, B. C., Li, Y. J. and Chen, X. : Asia Pacific Journal of Pharmacology. 4, 265 (1989)
  53. 이광수 : 인삼시험연구 용역보고서 (인삼이 심장비대증에 미치는 약리작용에 관한연구). 한국인삼연초연구소, 1981
  54. Ding, K. T., Shen, T. K, Cui, Y. Z. : 中國中西醫結合雜誌, 15(6), 325 (1995)
  55. Shin, H. R. et al. : Cancer Causes and Control 11, 565 (2000)
  56. Yun, T. K : Nutrition Reviews 54(1), S71 (1996) https://doi.org/10.1111/j.1753-4887.1996.tb03822.x
  57. Chen, X., Liu, H., Lei, X., Fu, Z., Li, Y., Tao, L. and Han, R. : J. of Ethnopharmacology 60, 71 (1998)
  58. Li, W., Wanibuchi, H., Salim, E. I., Wei, M., Yamamoto, S., Nishino, H. and Fukushima, S. : Nutrion and Cancer, 36(1), 66 (2000) https://doi.org/10.1207/S15327914NC3601_10
  59. Wu, X. G., Zhu, D. H., Li, X. : J Korean Med Sci 16(Suppl), S66 (2001)
  60. Nishino, H., et al. : J Korean Med Sci 16(Suppl), S66 (2001)
  61. Yun, T. K. and Choi, S. Y.: Int'l J of Epidemiology 19(4),871 (1990) https://doi.org/10.1093/ije/19.4.871
  62. Yun, T. K. and Choi, S. Y. : Cancer Epidemiology, Biomakers & Prevention 4, 401 (1995)
  63. Yun, T. K. and Choi, S. Y. : International Epidemiological Association 27, 359 (1998)
  64. Yun, T. K. : The Lancet Oncology 21(1), 49 (2001) https://doi.org/10.1016/S1470-2045(00)00196-0
  65. Lee, B. M., Lee, S. K, Kim, H. S. : Cancer Letters 132, 219 (1998)
  66. 山本 裕士, 片野 光男, 松永尙: 藥用A參’89, 共立出版, 東京, p. 220-223 (1989)
  67. Chang, Y. S., et al. :Korean J of Ob.& Gyn. 21(4), 253 (1978)
  68. Katano, M. and Yamamoto, H.: Linshio & Kenkyhu 64(7), 271 (1988)
  69. Suh, S.O., Jeung, C. H. and Soo, G. S.: The Ginseng Review. 25, 78 (1998)
  70. Scaglione, E, Ferrara, E, Dugnani, S., Santoro, G., Frachini, E: Drugs Exptr Clin Res 16(10), 537 (1990)
  71. Cho, Y. K, et al. :Int'l Immunopharmacology 1 (2001)
  72. Cho, Y. K, et al. : J. of Korean Association of Cancer Prevention, 1, 131 (1997)
  73. Chang, Y. S., et al. : Proc. of the 3rd Intl' Ginseng Symp. Seoul, 197 (1980)
  74. No, H. T., et al. : The New Medical J. 35(2), 40 (1992)
  75. Nagata, K, et al.: Proc. of '97 Korea-Japan Ginseng Symp., 58 (1997)
  76. Nocerino, E., Amato, M. and Izzo, A A. : Fitoterapia 71, S1 (2000)
  77. Lee, H. Y., Pack, J. S. and Lee, S. W. : Korean J of Ural. 29(6), 950 (1988)
  78. Phamacopoeia of the People's Republic of China (English ed. 1997) Volume 1, Compliled by the Pharmacopoeia Commission Of PRC, Chemical Industry Press Beijing, China, 151 (1997)
  79. Gillis, C. N. : Biochem Pharmacol, 54, 1 (1997)
  80. Kim (Jun), H. Y., Chen, X. and Gillis, C. N. : Biochemical and Biophysical Research Communations 189(2), 670(1992) https://doi.org/10.1016/0006-291X(92)92253-T
  81. Chen, X., Lee, T. J. E: Br J Pharmacol 115, 15 (1995)
  82. Choi, Y. D., Xin, Z. C. and Choi, H. K: Int'l J Impotence Research 10, 37 (1998).
  83. Choi, Y. D., Rha, K. H. and Choi, H. K.: The Journal of Urology 162, 1508 (1999) https://doi.org/10.1016/S0022-5347(05)68349-8
  84. Yoshimura, H., Kimura, N. and Sugiura, K.:Meth Find Clin Pharmacol 20(1), 59 (1998) https://doi.org/10.1358/mf.1998.20.1.485633
  85. Yoshimura, H. and Kimura, N.: The Ginseng Review 14, 100 (1992)
  86. Choi, H. K, Seong, D. H. and Rha, K. H.: Int. J. Impotence Res. 7, 181 (1995)
  87. Kim, S. W. and Paick, J. S. : Kor J Androl. 17(1), 23(1999)
  88. Hong, B., Ji, Y. H., Hong, J. H., Nam, K Y. and Ahn, T. Y. : 8th Asia-Pacific Society for Impotence Research & Exhibition (APSIR), Sexual Dysfunction for the New millenium October 23rd-26th, 2001, Phuket. Thailand, Abstract Book OR3 (2001)
  89. Choi, H. K and Choi, Y. D.: Proceedings of '99 Korea-Japan Ginseng Symposium, 97 (1999)
  90. Lee, H. Y. and Kim, C. S. : Korean J of Urol, 27(2), 235 (1986)
  91. Ishigami, J., Saito, H., Karnidono, S. : 日本不班學會雜誌 16(4), 45 (1971)
  92. Shida, K, et al. ; 日本不任學會雜誌 16, 85 (1970)
  93. Ishigami, J., et al: Clinical Evaluation, 5(2), 205 (1977)
  94. Salvati, G., Genovesi, G., Marcellini, E, De, Nuccio, I., Pepe, M. and Re, M. : Panminerva Med 38(4), 249 (1996)
  95. Brekhman, I. I. and Dardymov, I. V. : Ann Rev Pharmacol 69, 419 (1969)
  96. Wagner, H., Norr, H. and Winterhoff, H.: Phytomedicine 1, 63 (1994) https://doi.org/10.1016/S0944-7113(11)80025-5
  97. Fulder, S. J., et al. ;Proc. 3rd Int'l Ginseng Symp. Seoul, Korea, 81 (1980)
  98. Kaneko, H., et al. : Linshiou & Kenkyu, 59(12), 137 (1984)
  99. Pieralisi, G., et at. : Clin. Therap. 13, 373 (1991)
  100. Kaneko, H., Nakanishi, K, et al. : Proc. '97 Korean-Japan Ginseng Symp. 121 (1997)
  101. Scaglione, E, et al. : Drugs Exptl Clin Res 22(2), 65 (1996)
  102. 金子仁: 日本醫事新報, NO 3918, 61 (1999)
  103. Koike, Y., et al. : The Ginseng Review 25, 7 (1998)
  104. Bahrke, M. and Morgan, W. E: Sports Med. 29(2), 113 (2000) https://doi.org/10.2165/00007256-200029020-00004
  105. Antonio, C, et al. : Comperatioe Biochemistry and Physiology, Part C 130, 369 (2001)
  106. Ziemba, A w., et al. :Int'l J of Nutrition 9, 371 (1999)
  107. Engels, H. and Wirth, J. C.:J Am Diet Assoc, 97, 1110 (1997)
  108. Allen, J. D., et al. :J of the America College of Nutrition 17(5), 462 (1998) https://doi.org/10.1080/07315724.1998.10718795
  109. Fouad, A A, et al. :Alex J Pharm Sci 10(3), 219 (1996)
  110. Forgo, I., et al. : Mediziniscle Welt 32, 751 (1981)
  111. Brekhman, I. I. : Proceedings of Ginseng, Symposium of Geronotology, Lugano, The Research Institute, Office of Monopoly, ROK, 5 (1976)
  112. Dorling, E., et al. : Notabene Medici 10, 245 (1980)
  113. Morue, S. : Acta Physiol Lat. Am. 34, 521 (1983)
  114. Bucci, L. R: Am. J Clin. Nutr. 72(Suppl), S624 (2000) https://doi.org/10.1093/ajcn/72.2.624S
  115. Carso, Masco, A, et al.: Drugs Expt; Clin. Res. 22(6), 323 (1996)
  116. Tode, T., Kikuchi, Y., Hirata, J., Kita, T. and Nagata, I. : Int J Gynecol Obstet 67, 169 (1999) https://doi.org/10.1016/S0020-7292(99)00168-X
  117. Wiklund, I. K, Mattsson, L. A, Lindgren, R, Limoni, C. : International J of Clinical Pharmacology Research, 19(3), 89 (1999)
  118. Jin, S. H., Park, J. K, Nam, K. Y., et al. : J of Ethnopharmacology 66, 123 (1999) https://doi.org/10.1016/S0378-8741(98)00190-1
  119. Chepurnov, S. A, et al.: Bulletin of Expermenial Biology and Medicine, 122(9), 872 (1996) https://doi.org/10.1007/BF02446567
  120. Ono, T., et al. : Physiology & Behavior 69, 555 (2000)
  121. Wen, T. c., Yoshimura, H., Matsuda, S., Lim, J. H. and Sakanmaka, H. : Acta Neuropathol 91, 15 (1996)
  122. Sorensen, H. and Sonne, J.: Current Therapeutic Research, 57(12), 959 (1996) https://doi.org/10.1016/S0011-393X(96)80114-7
  123. Kennedy, D., Scholey, A., Wesne, K A: Phytomed 7(Suppl. II), 105 (2000)
  124. Wesnes, K. A, Ward, T., McGinty, A., Petrini, O. : Psycopharmacology 152, 353 (2000)
  125. Lee, Tze-fun, Shiao, Young-ji, Chen, Chieh-Fu, Wang Lawrence, C. H. : Planta Medica 67, 634 (2000)
  126. Ott, B. R. and Owens, N. : J of Geritric Psychology and Neurology 11, 163 (1998) https://doi.org/10.1177/089198879901100401
  127. Yun, T. K, Lee, Y. H., Kim, S. I., Yun, H. Y. : J Korean Med Sci 16(Suppl), S66 (2001) https://doi.org/10.3346/jkms.2001.16.S.S66
  128. Park, J. D., Kim, Y. S., Park, K. M., Shin, H. J., Jeong, T. C., Lee, Y. H. and Nam, K Y. : Proc. of '99 KoreaGinseng Symp., 191 (1999)
  129. Tode, T., Kikuchi, Y., Kita, T., Hirata, J., Imaizumi, E., Nagata, I.:J. Cancer Res. Clin Oncol. 120, 24 (1993) https://doi.org/10.1007/BF01200720
  130. Rhee, Y. H., Choe, J. H., Kang, K. W. and Joe, C. : Planta Medica 57, 125 (1991)
  131. Lee, B. H., Lee, S. J., Hui, J. H., Lee, S. Y., Sung, J. H., Hun, J, D. and Moon, C. K.: Planta Medica 64, 500 (1998) https://doi.org/10.1055/s-2006-957501
  132. Kim, K. W, Lee, Y. S., Jung, I. S., Park, S. Y., Chung, H. Y., Lee, L R. and Yun, Y. S. : Plania Medica 64, 110 (1998) https://doi.org/10.1055/s-2006-957385
  133. Lee, Y. S., Chung, I. S., Lee, I. R., Kim, K. H., Hong, W. S., Yun, Y. S.: Anticancer Res. 17, 323 (1997)
  134. Park, K. M., Kim, Y. S., Jeong, T. C., Joe, c. H., Shin, H. J., Lee, Y. H., Nam, K. Y. : Planta Medica 67, 122 (2000) https://doi.org/10.1055/s-2001-11508
  135. Kim, K. W, Jung, I. S., Chung, H. Y., Jo, S. K and Yun, Y. S. : Korean J. Ginseng Sci. 21(2), 78 (1997)
  136. Kim, Y. S., Kim, D. S. and Kim, S. I. : The International J. of Biochemistry & Cell Biology 30, 327 (1998) https://doi.org/10.1016/S1357-2725(97)00141-6
  137. Park, J, A., Lee, K. Y., Oh, Y. I., Kim, K. W. and Kim, S. I. : Cancer Letters 121, 73 (1997) https://doi.org/10.1016/S0304-3835(97)00333-9
  138. Lee, K. Y., Lee S. K.: Anticancer Res 17(2), 1067 (1997)
  139. Shinkai, K, Akedo, H., Mukai, M., Imamura, E, lsoai, A., Kobayashi, M. and Kitagawa, I. : Jpn J Cancer Res 87, 357 (1996) https://doi.org/10.1111/j.1349-7006.1996.tb00230.x
  140. Mochizuki, M., Yoo, Y. c., Matsuzawa, K, Sato, K., Saiki, I., Iono-Oka, S., Samukawa, K. and Azuma, I. : Biol Pharm Bull 18(9), 1197 (1995) https://doi.org/10.1248/bpb.18.1197
  141. Wakabayashi, C., Hasegawa, H., Murata, J, and Saiki, I. : Oncology Research 9, 411 (1997).
  142. Hasegawa, H., Lee, K S., Nagaoka, T., Tezuka, Y., Uchiyama, M., Kadota, S., Saiki, I. : Biol Pharm Bull 23(3), 298 (2000) https://doi.org/10.1248/bpb.23.298
  143. Kanaoka, M., Akao, T. and Kobashi, K. : J. of Traditional Medicine 11, 241 (1994)
  144. Sato, K, Mochizuki, M., Saiki, I., Yoo, Y. C., Samukawa, K. and Azuma, I.: Biol Pharm Bull 17(5), 635 (1994) https://doi.org/10.1248/bpb.17.635
  145. 대한약전외 생약규격집(주해서) : 지형준, 이상인 편저, 한국메디칼인텍스사, 518 (1988)
  146. 中華人民共和國藥典(1部) : 國家藥典委員會 編, 化學工業出版社(北京), p. 6-7, p. 121 (2000)
  147. 日本藥局方解說書: 光川書店(東京), D-302-304, D-714 (1991)
  148. The Complete German Commission E Monographs : American Botanical Council, Austin, 138 (1998)
  149. World Health Organization: WHO Monographs on selected medicinal plants, Radix Ginseng Vol. 1. WHO, Geneva., 168 (1999)
  150. Harkey, M. R., Henderson, G. L., et al : The American J. of Clinical Nutrition, 73, 1101 (2001) https://doi.org/10.1093/ajcn/73.6.1101
  151. Khan, I. A., Allgood, J., et al. : J. of AOAC International, 84, 936 (2001)
  152. Cui, J, E, Garle, M., Bjorkhem, L, Eneroth, P. : Scan J Clin Invest, 56, 151 (1996) https://doi.org/10.3109/00365519609088602
  153. TreatmentUpdate 119, 13(3), 3 (2001)
  154. Sonnenbom, U. and Hansel : In De Smet PAGM et al., eds. Adverse Reaction of Herbal Drugs, Springer. Verlag, Berlin, 179 (1992)
  155. Ioana, G., Carabin, George, A., Burdock and Chris, Chatzdakis : Internation J. of Toxicology, 19, 293 (2000) https://doi.org/10.1080/10915810050202105
  156. Dega, R., et al. : The LANCET, 347, 1344 (1996)
  157. Gonzalez-Seijo, J. C., Ramos, Y. M. and Lastra, 1. : J Clin Psychopharmacol, 15(6), 447 (1995) https://doi.org/10.1097/00004714-199512000-00014
  158. Ryu, S. J. and Chien, Y. Y.:Neurology, 45, 829 (1995)
  159. Koren, G., et al. : JAMA, 264(22), 2866 (1990) https://doi.org/10.1001/jama.264.22.2866b
  160. Awang, Dennis, V. C. : JAMA, 266(3), 363 (1991) https://doi.org/10.1001/jama.266.3.363
  161. Sonnenbom, U. and Proppert, Y. : British J of Pharmacology, 2(1), 3 (1991)
  162. Watt, J., Bottomley, M., et at. : Br J Sp Med, 23(2), 76 (1988) https://doi.org/10.1136/bjsm.23.2.76
  163. Becker, B. N., et al. : JAMA, 276(3), 606 (1996) https://doi.org/10.1001/jama.276.8.606
  164. Vogler, B. K, et al. : Eur J Clin Pharmacal 55, 567 (1999) https://doi.org/10.1007/s002280050674
  165. Jones, B. D., Runiks, A. M. : J Clin Psychopharmacol. 7, 201 (1987) https://doi.org/10.1097/00004714-198706000-00030
  166. Janetzky, K, Morreale, A. P.: Am J Health-Syst Pharm. 54, 692 (1997)
  167. Bae, E. A, Han, M. J., Choo, M. K., Park, S. Y. and Kim, D. H. : Biol Pharm Bull 25(1), 58 (2002) https://doi.org/10.1248/bpb.25.58
  168. Karikura, M. : Chem. Pharm. Bull., 39, 2357 (1991)
  169. Kaneko, H., Nakanishi, K, et al. : Ther Res 17, 405(1996)
  170. Sakada, T., Sunega, K, Yoshimatsu, H.: Proc. '99 Korean Japan Ginseng Symp., 32 (1999)
  171. Nam, K. Y. and Park, J. D.: J Ginseng Res. 24(2), 99 (2000)
  172. Cui, J., Garle, M., Eneroth, P., Bjorkhem, L.: The LANCET, 344, 134 (1994) https://doi.org/10.1016/S0140-6736(94)91322-6
  173. Cui, J. E., Garle, M., Bjorkhem, I. and Invest, P. : Scand J Lab Invest 56, 151 (1996) https://doi.org/10.3109/00365519609088602
  174. Shibata, S. : J Korean Med Sci 16(Suppl), S28 (2001) https://doi.org/10.3346/jkms.2001.16.S.S28

피인용 문헌

  1. Detection of Radiation Induced Markers in Oranges Imported from the United States of America vol.32, pp.1, 2003, https://doi.org/10.3746/jkfn.2003.32.1.001
  2. Effect of Korean Red Ginseng Powder on the Lipid Concentrations and Tissue Lipid Peroxidation in the Rats Fed High Fat Diet vol.32, pp.1, 2003, https://doi.org/10.3746/jkfn.2003.32.1.124
  3. Saponin Composition and Physico-Chemical Properties of Korean Red Ginseng Extract as Affected by Extracting Conditions vol.37, pp.2, 2008, https://doi.org/10.3746/jkfn.2008.37.2.256
  4. Ginseng Intake and Gastric Cancer Risk: A Meta-Analysis of Observational Epidemiological Studies vol.31, pp.12, 2010, https://doi.org/10.4082/kjfm.2010.31.12.930
  5. Oral Toxicity Study on the 90-day Repeated-dose of 50 kGy Irradiated Methanol Extract Powder of Red Ginseng vol.40, pp.6, 2011, https://doi.org/10.3746/jkfn.2011.40.6.824
  6. Anti-inflammatory Effects of Inhalation of Injured Starfish Extracts on Formaldehyde Exposure vol.23, pp.4, 2013, https://doi.org/10.5352/JLS.2013.23.4.501
  7. Evaluation of Residual Pesticides in Fresh Ginseng Collected in Seoul vol.56, pp.1, 2013, https://doi.org/10.3839/jabc.2013.006
  8. spp Root-Derived Ingredients as Used in Cosmetics vol.34, pp.3_suppl, 2015, https://doi.org/10.1177/1091581815610508
  9. Antioxidant Activities and Quality Characteristics of Jelly Added with Saengmaegsan Concentrate vol.44, pp.3, 2015, https://doi.org/10.3746/jkfn.2015.44.3.393
  10. Identification of suitable sites for mountain ginseng cultivation using GIS and geo-temperature vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-2031-x
  11. Transcriptome analysis using de novo RNA-seq to compare ginseng roots cultivated in different environments pp.1573-5087, 2017, https://doi.org/10.1007/s10725-017-0328-6
  12. Quality Characteristics of Panax ginseng C. A. Meyer with Steaming Heat and Wet Grinding Conditions vol.39, pp.7, 2010, https://doi.org/10.3746/jkfn.2010.39.7.1005
  13. Quality Characteristics of 4 Year-old Ginseng by Enzymatic Hydrolysis Conditions vol.40, pp.2, 2011, https://doi.org/10.3746/jkfn.2011.40.2.229
  14. Quality Characteristics of Topokki Garaedduk Added with Ginseng Powder vol.40, pp.3, 2011, https://doi.org/10.3746/jkfn.2011.40.3.426
  15. Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study vol.25, pp.2, 2013, https://doi.org/10.1038/ijir.2012.45
  16. Effects of Quality Characteristics and Antioxidant Activity of Korean Cultivated Wild Ginseng Extract vol.45, pp.12, 2016, https://doi.org/10.3746/jkfn.2016.45.12.1740
  17. Physicochemical characteristics and ginsenoside content of Korean traditional wine produced by fermentation of Panax ginseng sprouts vol.25, pp.6, 2018, https://doi.org/10.11002/kjfp.2018.25.6.659
  18. Development and characterization of new microsatellite markers in Panax ginseng (C.A. Meyer) from BAC end sequences vol.11, pp.3, 2010, https://doi.org/10.1007/s10592-009-9924-y